Health Technology Assessment in China's Health Care Sector: Development and Applications

• Published in: Health systems and reform 2023-12, Vol.9 (3), p.2327099
• Main Authors: Guo, Wudong, Wang, Peimeng, Zhang, Yuzheng, Li, Xue, Wang, Yaoling, Zhao, Kun, Ruiz, Francis, Li, Rui, Xiao, Feiyi, Gu, Xuefei, You, Mao, Fu, Qiang
• Format: Article
• Language: English
• Subjects: China; China health technology assessment; health care policy making; Health Care Reform - methods; Health Care Reform - trends; Health Care Sector - trends; Health Policy; Humans; Insurance, Health - statistics & numerical data; Insurance, Health - trends; medical insurance; National Reimbursement Drug List; Technology Assessment, Biomedical - methods
• ISSN: 2328-8604; 2328-8620; 2328-8620
• DOI: 10.1080/23288604.2024.2327099

China's health system is facing severe challenges from social transition and the double burden of population aging and non-communicable diseases. Addressing the tension between the public's increasing demand for health services and the limited availability of medical resources has become a critical issue for health care policymakers and medical insurance fund administrators. In promoting its medical insurance system reform, China is actively developing health technology assessment (HTA) with principles and applications adapted to the Chinese context. This study aims to analyze the evolution of HTA in China with a focus on context, actors, process, content, and challenges encountered through applying a modified verson of Walt and Gilson's policy triangle framework. Currently, HTA plays an indispensable part in the reform of China's health care and medical insurance system, especially in the formulation and adjustment of the National Reimbursement Drug List (NRDL). While HTA is increasingly used in China, there remain challenges, such as the slow development of HTA related disciplines, lack of an independent national HTA authority, and limited scope in the use of HTA. Despite the identified challenges, HTA has the potential to support a wide range of applications in China's health care sector, building on the progress achieved over the last three decades.